These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 26239001

  • 21. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S, Ranju V, Kalaivani P, Priya RJ, Sumathy H, Sunil AG, Babu CS.
    Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
    [Abstract] [Full Text] [Related]

  • 22. Chronic rotenone treatment induces behavioral effects but no pathological signs of parkinsonism in mice.
    Richter F, Hamann M, Richter A.
    J Neurosci Res; 2007 Feb 15; 85(3):681-91. PubMed ID: 17171705
    [Abstract] [Full Text] [Related]

  • 23. Characterisation of a novel model of Parkinson's disease by intra-striatal infusion of the pesticide rotenone.
    Mulcahy P, Walsh S, Paucard A, Rea K, Dowd E.
    Neuroscience; 2011 May 05; 181():234-42. PubMed ID: 21277943
    [Abstract] [Full Text] [Related]

  • 24. Dose-dependent loss of motor function after unilateral medial forebrain bundle rotenone lesion in rats: a cautionary note.
    Klein A, Gidyk DC, Shriner AM, Colwell KL, Tatton NA, Tatton WG, Metz GA.
    Behav Brain Res; 2011 Sep 12; 222(1):33-42. PubMed ID: 21419806
    [Abstract] [Full Text] [Related]

  • 25. Effects of oral administration of rotenone on gastrointestinal functions in mice.
    Tasselli M, Chaumette T, Paillusson S, Monnet Y, Lafoux A, Huchet-Cadiou C, Aubert P, Hunot S, Derkinderen P, Neunlist M.
    Neurogastroenterol Motil; 2013 Mar 12; 25(3):e183-93. PubMed ID: 23281940
    [Abstract] [Full Text] [Related]

  • 26. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
    Recchia A, Rota D, Debetto P, Peroni D, Guidolin D, Negro A, Skaper SD, Giusti P.
    Neurobiol Dis; 2008 Apr 12; 30(1):8-18. PubMed ID: 18313315
    [Abstract] [Full Text] [Related]

  • 27. Puerarin protects dopaminergic neurons in Parkinson's disease models.
    Zhang X, Xiong J, Liu S, Wang L, Huang J, Liu L, Yang J, Zhang G, Guo K, Zhang Z, Wu P, Wang D, Lin Z, Xiong N, Wang T.
    Neuroscience; 2014 Nov 07; 280():88-98. PubMed ID: 25218963
    [Abstract] [Full Text] [Related]

  • 28. MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut.
    Natale G, Kastsiushenka O, Fulceri F, Ruggieri S, Paparelli A, Fornai F.
    Brain Res; 2010 Oct 08; 1355():195-206. PubMed ID: 20691673
    [Abstract] [Full Text] [Related]

  • 29. Oral administration of rotenone using a gavage and image analysis of alpha-synuclein inclusions in the enteric nervous system.
    Pan-Montojo FJ, Funk RH.
    J Vis Exp; 2010 Oct 26; (44):. PubMed ID: 21085094
    [Abstract] [Full Text] [Related]

  • 30. Protective effect of roscovitine against rotenone-induced parkinsonism.
    Chen Y, Hou Y, Ge R, Han J, Xu J, Chen J, Wang H.
    Restor Neurol Neurosci; 2018 Oct 26; 36(5):629-638. PubMed ID: 30056439
    [Abstract] [Full Text] [Related]

  • 31. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.
    Testa CM, Sherer TB, Greenamyre JT.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):109-18. PubMed ID: 15790535
    [Abstract] [Full Text] [Related]

  • 32. Hydroxysafflor Yellow A Improves Motor Dysfunction in the Rotenone-Induced Mice Model of Parkinson's Disease.
    Wang T, Wang L, Li C, Han B, Wang Z, Li J, Lv Y, Wang S, Fu F.
    Neurochem Res; 2017 May 24; 42(5):1325-1332. PubMed ID: 28097465
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
    Nehru B, Verma R, Khanna P, Sharma SK.
    Brain Res; 2008 Mar 27; 1201():122-7. PubMed ID: 18308296
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
    Parkhe A, Parekh P, Nalla LV, Sharma N, Sharma M, Gadepalli A, Kate A, Khairnar A.
    Neurosci Lett; 2020 Jan 18; 716():134652. PubMed ID: 31778768
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.